Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Modality
1.1.2. End-use
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Modality outlook
2.2.2. End-use outlook
2.3. Competitive Insights
Chapter 3. U.K. Imaging Services Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing prevalence of chronic disorders
3.4.1.2. Technological advancements
3.4.1.3. Growing awareness of medical imaging
3.4.2. Market restraint analysis
3.4.2.1. High radiation exposure
3.4.2.2. Lack of technically sound staff
3.5. U.K. Imaging Services Market Analysis Tools
3.5.1. Industry Analysis - Porter’s Five Forces
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. U.K. Imaging Services Market: Modality Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. X-rays
4.1.2. CT scans
4.1.3. MRI scans
4.1.4. Ultrasound
4.1.5. Nuclear Medicine scans
4.2. Modality Market Share, 2018 & 2030
4.3. Segment Dashboard
4.4. U.K. Imaging Services Market by Modality Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. X-rays
4.5.1.1. X-rays market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. CT scans
4.5.2.1. CT scans market estimates and forecast 2018 to 2030 (USD Million)
4.5.3. MRI scans
4.5.3.1. MRI scans market estimates and forecast 2018 to 2030 (USD Million)
4.5.4. Ultrasound
4.5.4.1. Ultrasound market estimates and forecast 2018 to 2030 (USD Million)
4.5.5. Nuclear medicine scans
4.5.5.1. Nuclear medicine scans market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. U.K. Imaging Services Market: End-use Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Hospitals
5.1.2. Diagnostic imaging centers
5.1.3. Others
5.2. End-use Market Share, 2018 & 2030
5.3. Segment Dashboard
5.4. U.K. Imaging Services Market by End-use Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Hospitals
5.5.1.1. Hospitals estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Diagnostic Imaging Centers
5.5.2.1. Imaging centers market estimates and forecast 2018 to 2030 (USD Million)
5.5.3. Others
5.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.2.1. Innovators
6.3. Vendor Landscape
6.3.1. List of key distributors and channel partners
6.3.2. Key customers
6.3.3. Key company market share analysis, 2021
6.3.4. Alliance Medical
6.3.4.1. Company overview
6.3.4.2. Financial performance
6.3.4.3. Product benchmarking
6.3.4.4. Strategic initiatives
6.3.5. InHealth Group
6.3.5.1. Company overview
6.3.5.2. Financial performance
6.3.5.3. Product benchmarking
6.3.5.4. Strategic initiatives
6.3.6. Neuromed Diagnostic Imaging Center
6.3.6.1. Company overview
6.3.6.2. Financial performance
6.3.6.3. Product benchmarking
6.3.6.4. Strategic initiatives
6.3.7. UNILAB
6.3.7.1. Company overview
6.3.7.2. Financial performance
6.3.7.3. Product benchmarking
6.3.7.4. Strategic initiatives
6.3.8. Medica Group
6.3.8.1. Company overview
6.3.8.2. Financial performance
6.3.8.3. Product benchmarking
6.3.8.4. Strategic initiatives
6.3.9. TIC Health
6.3.9.1. Company overview
6.3.9.2. Financial performance
6.3.9.3. Product benchmarking
6.3.9.4. Strategic initiatives
6.3.10. The radiology clinic
6.3.10.1. Company overview
6.3.10.2. Financial performance
6.3.10.3. Product benchmarking
6.3.10.4. Strategic initiatives
6.3.11. Affidea Group
6.3.11.1. Company overview
6.3.11.2. Financial performance
6.3.11.3. Product benchmarking
6.3.11.4. Strategic initiatives
6.3.12. Vista Health
6.3.12.1. Company overview
6.3.12.2. Financial performance
6.3.12.3. Product benchmarking
6.3.12.4. Strategic initiatives
6.3.13. Medical Imaging Partnership
6.3.13.1. Company overview
6.3.13.2. Financial performance
6.3.13.3. Product benchmarking
6.3.13.4. Strategic initiatives
6.3.14. Rutherford Diagnostics
6.3.14.1. Company overview
6.3.14.2. Financial performance
6.3.14.3. Product benchmarking
6.3.14.4. Strategic initiatives
6.3.15. Medical Imaging Partnership
6.3.15.1. Company overview
6.3.15.2. Financial performance
6.3.15.3. Product benchmarking
6.3.15.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 U.K. imaging services market, by modality (USD Billion) 2018 - 2030
Table 3 U.K. imaging services market, by end-use, (USD Billion) 2018 - 2030
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.K. imaging services market: market outlook
Fig. 9 U.K. imaging services market competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 U.K. imaging services market Driver Impact
Fig. 15 U.K. imaging services market Restraint Impact
Fig. 16 U.K. imaging services market Strategic Initiatives Analysis
Fig. 17 U.K. imaging services market: Type Movement Analysis
Fig. 18 Micro- MRI market: Modality outlook and key takeaways
Fig. 19 X-ray market estimates and forecast, 2018 - 2030
Fig. 20 CT scans market estimates and forecast, 2018 - 2030
Fig. 21 MRI scan market estimates and forecast, 2018 - 2030
Fig. 22 Ultrasound market estimates and forecast, 2018 - 2030
Fig. 23 Nuclear Medicine scans market estimates and forecast, 2018 - 2030
Fig. 24 U.K. imaging services Market: End-use Movement Analysis
Fig. 25 U.K. imaging services Market: End-use outlook and key takeaways
Fig. 26 Hospitals Market Estimates and Forecast, 2018 - 2030
Fig. 27 Diagnostic imaging centers Estimate and Forecast, 2018 - 2030
Fig. 28 Others Estimate and Forecast, 2018 - 2030
Fig. 29 Participant Categorization - U.K. imaging services market
Fig. 30 Market share of key market players - U.K. imaging services market